NASDAQ: CASI
Casi Pharmaceuticals Inc Stock Ownership - Who owns Casi Pharmaceuticals?

Insider buying vs selling

Have Casi Pharmaceuticals Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when CASI insiders and whales buy or sell their stock.

CASI Shareholders

What type of owners hold Casi Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Celgene Corp115.58%23,750,000$22.80MInsider
Dapeng Li57.78%11,872,026$11.40MInsider
Sparkle Byte Ltd49.63%10,198,518$9.79MInsider
Spectrum Pharmaceuticals Inc48.90%10,047,675$9.65MInsider
Idgaccel China Growth Fund III LP47.56%9,773,370$9.38MInsider
Wealth Strategy Holding Ltd44.23%9,087,888$8.72MInsider
Weiwu He12.46%2,560,265$2.46MInsider
Vr Adviser LLC4.80%987,259$947.77kInstitution
Foresite Capital Management VI LLC4.77%979,956$940.76kInstitution
James Huang3.84%788,374$756.84kInsider

1 of 3

CASI vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CASI3.18%96.82%
CTXR3.67%3.32%
GDTC0.16%57.45%
OSRH0.60%99.40%
HOTH8.61%52.08%Net Selling

Casi Pharmaceuticals Stock Ownership FAQ

Who owns Casi Pharmaceuticals?

Casi Pharmaceuticals (NASDAQ: CASI) is owned by 12.69% institutional shareholders, 386.93% Casi Pharmaceuticals insiders, and 0.00% retail investors. Celgene Corp is the largest individual Casi Pharmaceuticals shareholder, owning 23.75M shares representing 115.58% of the company. Celgene Corp's Casi Pharmaceuticals shares are currently valued at $22.80M.

If you're new to stock investing, here's how to buy Casi Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.